Latest filing published 02 Sept 2026 for BIOMERIEUX. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Valerie Leylde is a declared insider of Biomerieux (senior executive), with filings sourced from AMF. Between 26 February 2022 and 31 August 2026, the trades on record add up to 7 filings.
On the market, this insider has only ever bought: 4 purchases, €25k in total. The totals exclude 3 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants. Since January 2026: 1 purchase and no sales on the market.
Most recently, on 2 September 2026, the filings show an open-market purchase in Biomerieux. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations